AstraZeneca to acquire Alexion
Subject to approvals, the acquisition is expected to close in Q3 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
rare diseases
US FDA awards six clinical trials research grants to develop medical products for rare diseases
FDA received 47 clinical trial grant applications that were reviewed and evaluated for scientific and technical merit by more than…
Piramal Pharma Solutions to join hands with Epirium Bio to develop and manufacture orphan drugs
The integrated programme, involving three Piramal Pharma Solutions sites, encompasses formulation development, supply of APIs and…
US FDA approves Viltepso injection for treatment of Duchenne muscular dystrophy mutation
The approval was granted to NS Pharma
Licensing agreement deals decline in rare diseases space: GlobalData
Big pharma companies are searching for innovative biotechs to invest in the rare diseases space
Pharma industry seeks financial assistance from government for rare diseases
National level pharma associations organised a virtual meeting to discuss challenges, opportunities in this segment
Rare Diseases: Awaiting renewed focus
India needs to make significant investments in R&D, policy reforms, and measures to enable affordability and accessibility of…